Vimarsana
Biggest News Aggregation in the World

Page 21 - Antipsychotics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Antipsychotics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Antipsychotics Today - Breaking & Trending Today

New Med for Severe Mental Illness Tied to Less Weight Gain - Vimarsana News

New Med for Severe Mental Illness Tied to Less Weight Gain

A recently approved drug is associated with less weight gain in patients with severe mental illness. At least one expert says the actual difference in weight gain is of questionable clinical benefit.

New Study Helps Manage Weight Gain in Antipsychotic Users - Vimarsana News

New Study Helps Manage Weight Gain in Antipsychotic Users

National Institute for Health Research funded project will study non-pharmacological interventions for antipsychotic-induced weight gain

Methylphenidate Is Overprescribed to Children in France - Vimarsana News

Methylphenidate Is Overprescribed to Children in France

New prescriptions for methylphenidate have been increasing in France, data show. These prescriptions sometimes are written in the absence of a diagnosis of ADHD, which is the drug's only indication.

Brain Gamma Oscillations: A Novel Target in Schizophrenia? - Vimarsana News

Brain Gamma Oscillations: A Novel Target in Schizophrenia?

Targeting a potassium channel linked to brain gamma oscillations may offer a novel means of treating schizophrenia after patients showed improved symptom scores.

Novel Long-Acting Injection Cuts Schizophrenia Relapse - Vimarsana News

Novel Long-Acting Injection Cuts Schizophrenia Relapse

A novel risperidone formulation cuts relapse risk in schizophrenia, new research suggests; but experts wonder: will it help improve the field's "deplorably low" use of long-acting antipsychotics?